Andrew D. White

2.7k citations

37 papers · 2.0k indexed · 2 hit papers · h-index 18

Organic Chemistry top 5%
Biochemistry top 5%
Clinical Biochemistry top 5%
Biotechnology top 5%
Molecular Biology top 10%
- Receptor Mechanisms and Signaling 10
- Pharmacological Receptor Mechanisms and Effects 5
- Peroxisome Proliferator-Activated Receptors 4
- Chemical Synthesis and Analysis 4
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology 5
- Neuroscience and Neuropharmacology Research 3
Oncology
- Peptidase Inhibition and Analysis 3
Cancer Research
- Protease and Inhibitor Mechanisms 3

Co-authors: Steven V. Ley William P. Griffith Guy Perkins Akos A. Gerencser Ella Bossy‐Wetzel Blaise Bossy Mark H. Ellisman Jean‐Claude Martinou
Cited by: Organic Chemistry Biochemistry Clinical Biochemistry
Partner nations: United States France Poland

In The Last Decade

Andrew D. White

37 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2006 Nitric oxide‐induced mitochondrial fission is regulated by dynamin‐related GTPases in neurons
1987 Preparation and use of tetra-n-butylammonium per-ruthenate (TBAP reagent) and tetra-n-propylammonium per-ruthenate (TPAP reagent) as new catalytic oxidants for alcohols

Peers

Countries citing papers authored by Andrew D. White

Since Specialization

Citations

This map shows the geographic impact of Andrew D. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. White more than expected).

Fields of papers citing papers by Andrew D. White

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. White. The network helps show where Andrew D. White may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew D. White, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew D. White Line = papers co-authored together Andrew D. White links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor Livia Stanger,Adriana Yamaguchi,Pooja Yalavarthi,Sylviane Lambert,Devin Gilmore,Andrew Rickenberg,Catherine Luke,Kiran Kumar,T. Andrea,Andrew D. White,Niklas Bergh,Björn Dahlöf,Michael Holinstat	2023	9
2	Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity Işın Çakır,Colleen K. Hadley,Pauline Lining Pan,Rushita A. Bagchi,Masoud Ghamari‐Langroudi,Danielle T. Porter,Qiuyu Wang,M. Litt,Somnath Jana,Susan E. Hagen,Pil H. Lee,Andrew D. White,Jiandie D. Lin,Timothy A. McKinsey,Roger D. Cone	2022	46
3	An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation Lei Yu,Greggory Myers,Chia-Jui Ku,Emily Schneider,Yu Wang,Sharon Singh,Natee Jearawiriyapaisarn,Andrew D. White,Takashi Moriguchi,Rami Khoriaty,Masayuki Yamamoto,Michael G. Rosenfeld,Julien Pedron,John H. Bushweller,Kim‐Chew Lim,James Douglas Engel	2021	15
4	Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edema Xuwen Liu,Michael W. Wilson,Kun Liu,Pil H. Lee,Larisa Yeomans,Susan E. Hagen,Cheng‐mao Lin,Bo Wen,Duxin Sun,Andrew D. White,Hollis D. Showalter,David A. Antonetti	2020	1
5	S-3-Carboxypropyl-l-cysteine specifically inhibits cystathionine γ-lyase–dependent hydrogen sulfide synthesis Pramod Kumar Yadav,Victor Vitvitsky,Hanseong Kim,Andrew D. White,Uhn‐Soo Cho,Ruma Banerjee	2019	15
6	cis-1-Oxo-heterocyclyl-4-amido cyclohexane derivatives as NPY5 receptor antagonists James F. Burns,Bin Chen,Chien‐An Chen,Darı́o Doller,Eman Edelmenky,Yu Jiang,John Peterson,Michael Sabio,Jessie Weiss,Andrew D. White,Lingyun Wu,Rajinder Bhardwaj,Gamini Chandrasena,Noel J. Boyle,Xinyan Huang	2014	3
7	Fused thiazolyl alkynes as potent mGlu5 receptor positive allosteric modulators Mathivanan Packiarajan,Michel Grenon,Samuel Zorn,Allen T. Hopper,Andrew D. White,Gamini Chandrasena,Xiaosui Pu,Robbin Brodbeck,Albert J. Robichaud	2013	6
8	Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators Mathivanan Packiarajan,Christine G. Mazza Ferreira,Sang-Phyo Hong,Andrew D. White,Gamini Chandrasena,Xiaosui Pu,Robbin Brodbeck,Albert J. Robichaud	2012	12
9	N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators Mathivanan Packiarajan,Christine G. Mazza Ferreira,Sang-Phyo Hong,Andrew D. White,Gamini Chandrasena,Xiaosui Pu,Robbin Brodbeck,Albert J. Robichaud	2012	17
10	Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity Yulia E. Kushnareva,Akos A. Gerencser,Blaise Bossy,W-K Ju,Andrew D. White,Jenna Waggoner,MH Ellisman,Guy Perkins,Ella Bossy‐Wetzel	2012	92
11	Hydration of Zwitterionic Glycine Betaine and Analogues Through Molecular Simulation Andrew D. White,Shaoyi Jiang	2011	1
12	Strategies to lower the Pgp efflux liability in a series of potent indole azetidine MCHR1 antagonists Kai Lǚ,Yu Jiang,Bin Chen,Eman M. Eldemenky,Gil Ma,Mathivanan Packiarajan,Gamini Chandrasena,Andrew D. White,Kenneth Jones,Boshan Li,Sang-Phyo Hong	2011	11
13	Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder Douglas S. Johnson,Chung Sik Choi,Lorraine K. Fay,David A. Favor,Joseph T. Repine,Andrew D. White,Hyacinth C. Akunne,Lawrence W. Fitzgerald,Kim Nicholls,Bradley J. Snyder,Steven Z. Whetzel,Liming Zhang,Kevin A. Serpa	2011	19
14	6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics David A. Favor,James J. Powers,Andrew D. White,Lawrence W. Fitzgerald,Vincent E. Groppi,Kevin A. Serpa	2010	8
15	Synthesis of monofluorinated 1-(naphthalen-1-yl)piperazines Joseph T. Repine,Douglas S. Johnson,Andrew D. White,David A. Favor,Michael A. Stier,Judy Yip,Trent Rankin,Qizhu Ding,Samarendra N. Maiti	2007	11
16	Nitric oxide‐induced mitochondrial fission is regulated by dynamin‐related GTPases in neuronsbreakdown → Mark J. Barsoum,Hua Yuan,Akos A. Gerencser,Géraldine Liot,Yulia Kushnareva,Simone Gräber,Imre Kovács,Wilson D Lee,Jenna Waggoner,Jiankun Cui,Andrew D. White,Blaise Bossy,Jean‐Claude Martinou,Richard J. Youle,Stuart A. Lipton,Mark H. Ellisman,Guy Perkins,Ella Bossy‐Wetzel	2006	561
17	A Rationalization of the Acidic pH Dependence for Stromelysin-1 (Matrix Metalloproteinase-3) Catalysis and Inhibition Linda L. Johnson,A.G. Pavlovsky,Adam R. Johnson,Jeffrey A. Janowicz,Chiu-Fai Man,Daniel F. Ortwine,Claude F. Purchase,Andrew D. White,Donald Hupe	2000	64
18	X‐ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivity A.G. Pavlovsky,Mark Williams,Qi‐Zhuang Ye,Daniel F. Ortwine,Claude F. Purchase,Andrew D. White,V. Dhanaraj,Bruce D. Roth,Linda L. Johnson,Donald Hupe,Christine Humblet,Tom L. Blundell	1999	65
19	Emerging Therapeutic Advances for the Development of Second Generation Matrix Metalloproteinase Inhibitors Andrew D. White,Thomas Bocan,Peter A. Boxer,Janet T. Peterson,Denis J. Schrier	1997	37
20	A method utilizing human lymphocytes with in vitro metabolic activation for assessing chemical mutagenicity by sister-chromatid exchange analysis Andrew D. White,L. C. Hesketh	1980	30

About Andrew D. White

Andrew D. White is a scholar working on Biochemistry, Cellular and Molecular Neuroscience and Molecular Biology, having authored 37 papers that have together received 2.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers), Neuropeptides and Animal Physiology (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Chemical Synthesis and Analysis (4 papers), Peptidase Inhibition and Analysis (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). The work is most often cited by research in Organic Chemistry (666 citations), Biochemistry (135 citations) and Clinical Biochemistry (125 citations). Andrew D. White has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Steven V. Ley, William P. Griffith, Guy Perkins, Akos A. Gerencser, Ella Bossy‐Wetzel, Blaise Bossy, Mark H. Ellisman, Jean‐Claude Martinou, Jiankun Cui and Hua Yuan.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact